
How cannabis works as a muscle relaxer
Muscle spasms occur when nerve signals to a muscle become overactive or dysregulated — the muscle contracts but cannot release. This dysregulation often originates in the central nervous system, particularly in areas of the brain and spinal cord that are rich in cannabinoid (CB1) receptors.
When THC binds to CB1 receptors in the motor cortex, basal ganglia, cerebellum, and spinal cord, it dampens the overactive signalling that drives involuntary contractions. At the same time, CBD acts on CB2 receptors and several non-cannabinoid pathways to reduce the neuroinflammation that sensitises muscles and nerves in the first place. Together, they address two overlapping causes of spasms: hyperactive motor nerve firing and inflammatory sensitisation.
A 2016 study published in the Journal of Neurology, Neurosurgery & Psychiatry[1] found significant reductions in spasticity-related symptoms in MS patients using Sativex (a 1:1 THC:CBD oromucosal spray). A later review covering multiple trials concluded that more than half of patients with MS or spinal cord injuries reported clinically meaningful spasm relief — roughly 20% better than placebo across most trials.[2]
What THC does for muscle spasms
Tetrahydrocannabinol (THC) is the primary antispasmodic agent in cannabis. It:
- Binds to CB1 receptors in the brain and spinal cord, directly reducing the nerve over-firing that causes spasms
- Reduces the release of glutamate — the excitatory neurotransmitter most implicated in spasticity
- Acts as an analgesic, addressing the pain that often accompanies chronic muscle spasms
- Reduces muscle stiffness and the Ashworth Scale scores used to measure spasticity clinically[3]
What CBD does for muscle spasms
Cannabidiol (CBD) does not directly relax muscles the way THC does, but it supports spasm relief through complementary mechanisms:
- Reduces neuroinflammation — a key driver of spasticity in MS, spinal cord injury, and cerebral palsy
- Inhibits the reuptake of adenosine, an anti-inflammatory compound that promotes muscle relaxation
- Acts as an anticonvulsant, reducing the abnormal electrical activity in nerves that can trigger spasms
- Mitigates the psychoactive effects of THC, allowing patients to use effective doses without excessive intoxication
The role of terpenes
Terpenes in whole-plant cannabis products add further muscle-relaxing effects through the entourage effect:
| Terpene | Relevance for muscle spasms |
|---|---|
| Myrcene | Sedative and muscle-relaxant properties; synergises with THC to deepen physical relaxation |
| Beta-caryophyllene | CB2 agonist — directly reduces neuroinflammation and sensitised pain responses in spastic muscles |
| Linalool | Calming and anxiolytic; reduces stress-triggered spasms and nighttime spasticity flares |
| Limonene | Anti-inflammatory; may help with exercise-induced and injury-related muscle spasms during daytime use |
| Pinene | Bronchodilator and anti-inflammatory; may counteract short-term memory effects of THC at higher doses |
Choosing the right product and delivery method
The right approach depends on whether your spasms are acute (sudden, intense contractions) or chronic (ongoing spasticity), and whether they are linked to a neurological condition or a more common cause like overuse or dehydration. Here’s how to think about it:
For neurological spasticity (MS, spinal cord injury, cerebral palsy)
A balanced 1:1 CBD:THC product — sublingual tincture or capsule — is the most clinically supported starting point, reflecting the formulation used in Sativex trials. The CBD component reduces neuroinflammation while THC directly dampens spastic signalling. Evening dosing is typically preferred, as sedative effects are useful for nighttime spasms and sleep disruption.
For acute or exercise-related spasms
A fast-acting vaporised product or sublingual tincture offers the quickest relief — onset within 1–5 minutes for vaporised, 15–30 minutes for sublingual. A topical balm or cream applied directly to the affected muscle can help with localised spasms without any systemic or psychoactive effects, and is a good option for daytime use.
For chronic pain alongside spasms
A higher-THC product with myrcene-rich terpenes, used in the evening, addresses both the pain and the spasm component simultaneously. Indica-leaning formulations are generally preferred for their body-heavy, sedating effects. Work with a medical cannabis physician to find a ratio that controls symptoms without excessive daytime impairment.
Delivery methods compared
| Method | Onset / Duration / Best for |
|---|---|
| Sublingual (tincture/spray) | 15–30 min onset · 4–6 hrs · Best for consistent symptom control; mirrors the Sativex delivery route |
| Vaporised flower/concentrate | 1–5 min onset · 2–3 hrs · Best for acute spasm attacks; not recommended for lung-related conditions |
| Oral (capsules/edibles) | 30–90 min onset · 6–8 hrs · Best for overnight and sustained relief; not suitable for acute spasms |
| Topical (cream/balm) | 15–30 min local onset · No systemic effects · Best for localised spasms and daytime use without impairment |
| Transdermal patch | 1–2 hr onset · 8–12 hrs continuous · Good for chronic neurological spasticity requiring sustained dosing |
Dosing guidance
There is no universal dose for muscle spasms. Clinical trials for spasticity typically used low-to-moderate doses of THC (2.5–10 mg per dose). General guidance:
- Start with 2.5 mg THC (or 5–10 mg CBD for non-intoxicating approaches) and assess over 2–3 days before increasing
- For neurological spasticity, titrate slowly upward to the lowest effective dose — high doses of THC can sometimes worsen balance and coordination in MS patients
- Keep a symptom log tracking spasm frequency, intensity, and sleep quality to identify your optimal dose
- Work with a physician experienced in cannabis medicine for ongoing dose adjustments, especially if you take baclofen, tizanidine, or other muscle relaxants
⚠ Drug interactions to be aware of
Cannabis can interact with several medications commonly used for spasticity and neurological conditions. Baclofen, tizanidine, benzodiazepines, and opioids all have CNS depressant effects that may be amplified by cannabis — particularly THC. CBD can also affect the metabolism of some anticonvulsants (e.g. clobazam) and immunosuppressants via the CYP450 pathway. Always disclose cannabis use to your prescribing physician before starting.
Does muscle spasticity qualify for a medical marijuana card?
Yes — muscle spasms and spasticity are among the most widely recognised qualifying conditions for medical cannabis in the US. Most states list the condition either directly or through the underlying conditions that cause it:
| Condition | Qualifying status in MMJ states |
|---|---|
| Muscle spasms / spasticity | Directly listed in the majority of states with medical cannabis programs |
| Multiple sclerosis (MS) | Widely listed; spasticity is among the most documented cannabis-treatable MS symptoms |
| Spinal cord injury (SCI) | Listed in most states; spasm relief is one of the primary reasons SCI patients obtain MMJ cards |
| Cerebral palsy | Approved in many states; spasticity and movement disorders are core qualifying symptoms |
| Parkinson’s disease | Listed in a growing number of states; rigidity and tremor qualify in most programs |
| Chronic pain | Qualifies in every US medical state; covers spasm-related pain even if spasms alone are not listed |
| ALS | Qualifying condition in the majority of states; muscle stiffness and spasms are primary symptoms |
Leafwell’s licensed physicians can confirm your eligibility based on your specific state and diagnosis — typically in a same-day telehealth appointment. Even if your state does not explicitly list muscle spasms, the underlying condition or associated chronic pain almost always qualifies.
What are muscle spasms and spasticity?
Muscle spasms are sudden, involuntary contractions of one or more muscles that last from a few seconds to several minutes. They range from the familiar cramp after exercise to the severe, painful contractions experienced by people with neurological conditions. Muscle spasticity is a related but distinct condition — a state of prolonged abnormal muscle tone and stiffness caused by damage to the central nervous system, affecting entire muscle groups rather than isolated contractions.
Around 12 million people worldwide live with clinically significant muscle spasticity, with MS and spinal cord injuries as the leading causes. For many, spasticity is not just uncomfortable — it disrupts sleep, limits mobility, and significantly reduces quality of life.
Common causes
- Dehydration and electrolyte imbalance — most common cause of ordinary muscle cramps
- Overuse or muscle fatigue — exercise-related spasms in healthy individuals
- Multiple sclerosis (MS) — autoimmune demyelination disrupts nerve-to-muscle signals, causing chronic spasticity in 80% of patients
- Spinal cord injury (SCI) — interruption of descending motor pathways causes spastic paralysis below the injury level
- Cerebral palsy — early brain injury disrupts normal motor development, causing lifelong spasticity
- Stroke / traumatic brain injury (TBI) — motor cortex damage impairs voluntary muscle control
- Parkinson’s disease — dopamine loss leads to rigidity, tremor, and muscle stiffness
- ALS (Lou Gehrig’s disease) — progressive motor neuron degeneration causes muscle cramps, stiffness, and fasciculations
- Nerve compression — herniated discs, sciatica, and stenosis can trigger spasms in the muscles served by the compressed nerve
- Menstrual cramps (dysmenorrhea) — uterine muscle spasms driven by prostaglandin release
Symptoms
Depending on the cause and severity, symptoms may include:
- Sudden, sharp muscle pain or cramping
- A hard, visibly contracted muscle that can be felt under the skin
- Prolonged muscle stiffness or rigidity (spasticity)
- Reduced range of motion in affected joints
- Clonus — rhythmic, involuntary muscle jerking
- Sleep disruption caused by nocturnal spasms
- Bladder and bowel dysfunction (in neurological spasticity)
Conventional treatments
Standard treatment depends on cause and severity:
- Muscle relaxants — baclofen (oral or intrathecal pump), tizanidine, dantrolene, and diazepam are the most commonly prescribed for spasticity
- Botulinum toxin injections (Botox) — injected directly into overactive muscles to temporarily paralyse them; effective for focal spasticity in MS, CP, and post-stroke
- Physical therapy — stretching, range-of-motion exercises, and gait training help maintain mobility and reduce spasm frequency
- NSAIDs and analgesics — for spasm-related pain management
- Magnesium supplementation — commonly used for exercise and nocturnal cramps; supported by modest evidence
- Cannabinoid-based medicine — Sativex (nabiximols) is approved in the UK, Canada, and many European countries specifically for MS spasticity, and is available off-label in some US states via specialty physicians
Get your medical marijuana card
Connect with a licensed physician online in minutes.
Larger purchase limits Access to higher potency strains Save up to 40% on product taxes Enhanced legal protection
